ArticleBMJ open2021

Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.

Clémentine Roucher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.